Changes in both gp120 and gp41 can account for increased growth potential and expanded host range of human immunodeficiency virus type 1.
about
Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virusBack to the future: covalent epitope-based HIV vaccine development.Relationship between the V3 loop and the phenotypes of human immunodeficiency virus type 1 (HIV-1) isolates from children perinatally infected with HIV-1.Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein.Replication of macrophage-tropic and T-cell-tropic strains of human immunodeficiency virus type 1 is augmented by macrophage-endothelial cell contact.Adaptation of human immunodeficiency virus type 1 to cells expressing a binding-deficient CD4 mutant (lysine 46 to aspartic acid)CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody.Isolation of human immunodeficiency virus type 1 (HIV-1) RNA from feces by a simple method and difference between HIV-1 subpopulations in feces and serumAmino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope.Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1.Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated.Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription fHuman immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays.An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.Human immunodeficiency virus type 1 infection of the brain.Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivoMacrophage-tropic and T-cell line-adapted chimeric strains of human immunodeficiency virus type 1 differ in their susceptibilities to neutralization by soluble CD4 at different temperatures.Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor.Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex.A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism.Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure.
P2860
Q33707328-6D5B726E-2BC3-425B-9670-25014490B65CQ34597300-C2582C3D-0906-4783-BD60-6E4550D585C3Q35828735-8DE6AAA5-B316-4DA6-954D-1718DF445867Q35833979-64E8096B-B7A0-4BB1-93B1-AEF93F4DB653Q35837334-6E4C205F-C35C-4C9C-991F-F7F9E065B22EQ35838613-4C51567F-B232-481F-BE62-DF2EAAA03A9CQ35876191-1A318CF8-81A2-46A9-B09F-0E549BE588CCQ35890076-275D7A49-20F1-4994-B6D8-61CFB0AB01C2Q36519329-EE33715A-ABD5-4BAF-9AB7-C92BE30A3832Q36622298-7E5006F5-BE63-4C73-8F78-F134BA809E29Q36627098-658B13ED-226C-40B6-BAF7-3670287E2DB2Q36628256-ACC76002-AC18-489C-BC00-BC509E4B49ABQ36633683-290F325F-A808-4BDD-A14D-C5874A070A2CQ36636446-F0C807E7-B70A-4EAE-9E41-567E7264A9A8Q36637774-D180AF80-7965-4D78-8418-7730EA874F37Q36640545-CA975A79-0174-4F7E-B454-9D11EC2485AFQ36649929-A059670F-B2EC-4494-BBE5-8D315FEE22F0Q39313957-53A17951-F376-4D5A-8DE8-885CCA57E74EQ39359591-92C0DEE8-7F01-4F27-88DC-1DECDD470C74Q39878965-8647C449-A6E5-4ADB-B26E-97872B192B06Q40045600-BD1CA9EE-9995-4E96-959F-FB6C560B751AQ40567871-7E4C0644-1EDA-4BF1-BBCD-93EC3B99F224
P2860
Changes in both gp120 and gp41 can account for increased growth potential and expanded host range of human immunodeficiency virus type 1.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Changes in both gp120 and gp41 ...... immunodeficiency virus type 1.
@ast
Changes in both gp120 and gp41 ...... immunodeficiency virus type 1.
@en
type
label
Changes in both gp120 and gp41 ...... immunodeficiency virus type 1.
@ast
Changes in both gp120 and gp41 ...... immunodeficiency virus type 1.
@en
prefLabel
Changes in both gp120 and gp41 ...... immunodeficiency virus type 1.
@ast
Changes in both gp120 and gp41 ...... immunodeficiency virus type 1.
@en
P2093
P2860
P1433
P1476
Changes in both gp120 and gp41 ...... immunodeficiency virus type 1.
@en
P2093
P2860
P304
P407
P577
1992-07-01T00:00:00Z